Medical Marijuana Reduces Anxiety And Depression, New Federally Funded Study Shows

Medicinal marijuana was associated with “significant decreases in self -informed anxiety and depression” compared to before patients started with cannabis treatment, according to a new study financed in part by the National Institute of Drug Abuse (NIDA).

The observation study, published this month in the Journal of Affective Distras, observed 33 adults in Maryland with anxiety and/or depression “clinically significant” for a period of six months, evaluating them at the beginning, and then after one, three and six months from when patients began using medicinal cannabis.

“Significant decreases were observed from the beginning in anxiety and depression, with middle scores that fall below the clinically significant levels within three months after the beginning,” says the study. Participants also reported sustained reductions in anxiety and/or depression symptoms during the six -month study period.

The majority of patients chose Dominant Cannabis products from THC. In addition to self -informed benefits for mental health, they also reported a decrease in their perceived conduction capacity and an increase in high feeling.

“The acute effects depended on the dose,” the authors wrote: “10-15 mg of oral THC and at least 3 vaporized cannabis pispasses threw the most robust reductions in anxiety and depression.”

Among the participants, three quarters said they had previously used marijuana. A little more than a third (37 percent) said they had used cannabis in the last year.

At the time of the study, medicinal marijuana was legal in Maryland, but the substance remained illegal for non -medical use.

The team of six people behind the new study represents the Faculty of Medicine of the Johns Hopkins University, the Johns Hopkins School of Public Health, the Integral Center for Cancer Sidney Kimmel of the University and the Center for Alcohol Policies Research in Melbourne, Australia.

A section of conflict of interest in the report indicates that some members have received funds or currently work for companies involved in medicinal marijuana.

In addition to the financing of NIDA, the project also received support for a pilot subsidy from the Lambert Center for the study of medicinal cannabis and hemp at Thomas Jefferson University.

The authors said that while the new findingsstudyThey were promising, “controlled clinical trials are needed to research more thoroughly the efficacy and safety of medicinal cannabis for the management of acute anxiety and depression.”

Although psychedelics have demonstrated a growing promise to treat mental health conditions such as anxiety, depression and PTSD, some cannabis users have long reported that the substance helps control anxiety and depression. Several other recent studies also support the idea.

A recent study, for example, found that legalizing marijuana at the state level It led to less full recipes for anxiety medications, including benzodiazepines, antipsychotics and antidepressants.

Another investigation at the end of last year He found “accumulated” evidence that the CBD marijuana component “has antidepressant properties in humans and animals with few side effects” And it can also help in the reduction of inflammation and the formation of new brain cells.

“In short,” said that study, “there is increasing evidence that the CBD can be a promising candidate for the treatment of depression.”

Separate research backed by industry on possible CBD anti-language effects last year found thatAn oral CBD solution effectively discussed moderate anxiety, as well as associated depression and poor sleep qualityNo observed adverse events.

As for cannabis more widely, another study last year in medicinal marijuana for chronic pain and mental health found that participants overwhelmingly informed that cannabis reduced the severity of its depression, anxiety and sleep problems At least some degree.

Written by I am Adlin For the moment of marijuana | Outstanding image of Gina Coleman/Weed maps

The post Medicinal marijuana reduces anxiety and depression, shows a new study funded by the federal government first appeared in Mapache news.